Bilateral Transversus Abdominis Plane Block and Postoperative Pain Intensity After Elective Cesarean Delivery
TAP
Evaluation of the Effect of Bilateral Transversus Abdominis Plane Block on Postoperative Pain Intensity and Analgesia Consumption After Elective Cesarean Delivery
1 other identifier
interventional
60
1 country
1
Brief Summary
The patients planned to go under elective cesarean delivery under general anesthesia are randomly assigned to have either bilateral transversus abdominis plane (TAP) block or usual standard analgesics after cesarean. Pain score (Verbal Analog Scale VAS) and analgesic requirements are recorded. It's supposed that both are significantly reduced in patients undergoing TAP block.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable postoperative-pain
Started Sep 2008
Typical duration for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 20, 2009
CompletedFirst Posted
Study publicly available on registry
August 25, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2009
CompletedNovember 18, 2010
November 1, 2010
1 year
August 20, 2009
November 17, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain intensity after cesarean section
one year
Secondary Outcomes (1)
Analgesic prescribed measurement
one year
Study Arms (2)
TAP blockade
EXPERIMENTALbilateral TAP blockade at the end of cesarean delivery
No TAP
NO INTERVENTIONThese patients would have usual analgesic drugs after cesarean
Interventions
15 cc Bupivacaine 0.25% ,injected bilaterally in the TAP blockade arm
Eligibility Criteria
You may qualify if:
- Elective cesarean delivery
- Term pregnancies
- General anesthesia
- Pfannenstiel incision
You may not qualify if:
- No history of sensitivity to prescribed analgesic (Bupivacaine or related substances)
- No preeclampsia
- No history of psychologic disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sharati hospital
Tehran, Tehran Province, 14114, Iran
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laleh Eslamian, MD
Tehran University of Medical Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 20, 2009
First Posted
August 25, 2009
Study Start
September 1, 2008
Primary Completion
September 1, 2009
Study Completion
October 1, 2009
Last Updated
November 18, 2010
Record last verified: 2010-11